Cargando…
Recombinant ASF Live Attenuated Virus Strains as Experimental Vaccine Candidates
African swine fever (ASF) is causing a pandemic affecting swine in a large geographical area of the Eastern Hemisphere, from Central Europe to East and Southeast Asia, and recently in the Americas, the Dominican Republic and Haiti. The etiological agent, ASF virus (ASFV), infects both domestic and w...
Autores principales: | Gladue, Douglas P., Borca, Manuel V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146452/ https://www.ncbi.nlm.nih.gov/pubmed/35632620 http://dx.doi.org/10.3390/v14050878 |
Ejemplares similares
-
Deletion Mutants of the Attenuated Recombinant ASF Virus, BA71ΔCD2, Show Decreased Vaccine Efficacy
por: Lopez, Elisabeth, et al.
Publicado: (2021) -
ASF Vaccine Candidate ASFV-G-∆I177L Does Not Exhibit Residual Virulence in Long-Term Clinical Studies
por: Borca, Manuel V., et al.
Publicado: (2023) -
The Presence of Virus Neutralizing Antibodies Is Highly Associated with Protection against Virulent Challenge in Domestic Pigs Immunized with ASFV live Attenuated Vaccine Candidates
por: Silva, Ediane B., et al.
Publicado: (2022) -
CRISPR-Cas9, a tool to efficiently increase the development of recombinant African swine fever viruses
por: Borca, Manuel V., et al.
Publicado: (2018) -
Early protection events in swine immunized with an experimental live attenuated classical swine fever marker vaccine, FlagT4G
por: Holinka, Lauren G., et al.
Publicado: (2017)